JERUSALEM, Jan Thirty, 2009 - (HSMN NewsFeed) - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ) announced today that the U.S. Food and Drug Administration has granted final approval for the Company’s Abbreviated New Drug Application (ANDA) to market its ge…
Biopharmacueticals, Generics, FDA
Teva Medical, Risperidone, Risperdal, Janssen, antipsychotic

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Teva Announces Approval of Generic Risperdal(R) Oral Solution”
Leave a Comment